|
|
Volumn 341, Issue 7763, 2010, Pages 61-
|
|
Some clarification needed
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EXTAVIA;
INTERFERON BETA SERINE;
RECOMBINANT INTERFERON;
UNCLASSIFIED DRUG;
BETA INTERFERON;
DRUG COST;
HEALTH CARE;
HUMAN;
LETTER;
MEDICAL DECISION MAKING;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
MULTIPLE SCLEROSIS;
PRACTICE GUIDELINE;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
COST BENEFIT ANALYSIS;
ECONOMICS;
HEALTH CARE DELIVERY;
COST-BENEFIT ANALYSIS;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
|
|
EID: 77954524065
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.c3589 Document Type: Letter |
|
Times cited : (2)
|
|
References (2)
|
